Molecolar and cell biology / Advanced Bioinks / GelXA Laminink 411, Medium Ma, 0.25 LAP
Laminin’s properties essential to cell differentiation, migration and adhesion are now available in a stable and easy-to-use bioink. GelXA LAMININK 411 supports many different tissues, including cells from the pancreatic, vascular, immune, nervous and hematopoietic systems. This bioink is well-suited for culturing specialized cells, including pancreatic cells and neurons. Use it as a base material for developing pancreas models and studying brain and nerve tissue. GelXA LAMININK 411 is an enhanced formulation of our GelXA Bioink that contains several laminins and offers excellent printability and easy crosslinking, and is a great starting point for culturing many cell types in 3D. Also available with a CELLINK base. Uses Use as a throughput 3D model (deposited as droplets) with the BIO X Temperature Controlled or Syringe Printhead. As a bioprinted 3D construct as demonstrated in the Liver Tissue Model Kit Other specialized cell specific formulations available: GelXA LAMININK 111 GelXA LAMININK 121 GelXA LAMININK 521 GelXA LAMININK+ Description Available in 3 mL cartridges. Includes crosslinking agent. Sterile production and packaging. Two-month shelf life. For research use only. Not for human use. Product number: IK3X21230301 (1 x 3 mL) Product number: IK3X21230303 (3 x 3 mL) We began offering a new and improved GelXA formulation in September 2019. The new blend enables more efficient photocrosslinking and a slightly lower stiffness after ionic crosslinking. If you would like to order the previous version, our team can prepare it upon request. Specifications The bioink has the following quality criteria: Appearance Semi-translucent gel Sterility Sterile Endotoxin level <30 EU/mL Cell viability ≥75% viable mesenchymal stem cells for 7 days pH 6.5-7.4 GelMA degree of methacrylation 45-55% Viscosity 1-1 000 Pa·s
IK3X21230301GelXA Laminink 411, Medium Ma, 0.25 LAP 1 x 3ml
IK3X21230303GelXA Laminink 411, Medium Ma, 0.25 LAP 3 x 3ml
